United States Drug Enforcement Administration

WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...

WASHINGTON – The U.S. Drug Enforcement Administration has launched a new campaign encouraging the public to make Every Day Take Back Day by utilizing year-round collection sites to dispose of unneeded and unwanted medications. For more than a decade, DEA has worked with state and local law enforcement partners to...

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...

WASHINGTON – Today, the Drug Enforcement Administration released the final report of the Foreign Operations Review Team, which contains recommendations to improve the effectiveness and enhance the integrity of DEA’s foreign operations. In August 2021, DEA requested this comprehensive review, which was led by Jack Lawn, a former DEA Administrator...

WASHINGTON – "Today’s designation of Chuen Fat Yip under the U.S. Department of State’s Transnational Organized Crime Rewards Program marks the culmination of several years of law enforcement and prosecution efforts against one of the most prolific alleged distributors of illicit and dangerous drugs and precursor chemicals operating in China...

WASHINGTON—The Drug Enforcement Administration today announced a comprehensive review of DEA’s international operations and foreign footprint, including administrative and financial support for those operations from DEA headquarters. Administrator Anne Milgram has recommended a top to bottom review of foreign operations that will be overseen by an independent team. As part...

WASHINGTON – With the unprecedented worldwide health emergency brought on by COVID-19, last year was filled with new challenges and increased risks. While much of the world focused on combating the pandemic, DEA continued to implement initiatives to combat violent drug traffickers who were intent on flooding cities and rural...

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...